Repare Therapeutics Inc.·4

Jan 20, 4:42 PM ET

Zinda Michael 4

4 · Repare Therapeutics Inc. · Filed Jan 20, 2022

Insider Transaction Report

Form 4
Period: 2022-01-18
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2022-01-18+115,000115,000 total
    Exercise: $15.63Exp: 2032-01-17Common Shares (115,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on January 18, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION